Abbonarsi

PRIMARY PERCUTANEOUS APPROACH TO UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMA - 05/09/11

Doi : 10.1016/S0094-0143(05)70122-1 
Michel E. Jabbour, MD a, Arthur D. Smith, MD b
a Department of Urology, Hotel Dieu Hospital, Saint Joseph University Faculty of Medicine, Beirut, Lebanon (MEJ) 
b Department of Urology, Long Island Jewish Medical Center, Albert Einstein College of Medicine, New Hyde Park, New York (ADS) 

Riassunto

Nephroureterectomy with excision of a bladder cuff has been the standard form of treatment of upper urinary tract transitional cell carcinoma (TCC) since it was established by Kimball and Ferris in 1934.42 Any technique that is short of total extirpation of the involved upper tract was considered to expose the patient to cancer-related risks because of the multifocality and the high recurrence rate of these tumors.31, 80 As many as two thirds of ureteropelvic tumors may show certain degrees of multiplicity, and less radical surgeries may end up with a urothelial recurrence rate of more than 65%.2, 48 The radical attitude was justified further by the low incidence of bilateral tumors (< 5%) and the limitations of upper tract endoscopic control.12, 26, 44, 77

Nephroureterectomy, however, is a major operation that may not be tolerated by many patients in the age range in which upper tract TCC is most common (60–80 years of age).16 The extent of its standard incision also cannot be minimized without compromising its efficiency.43, 46, 87, 91 Trying to simplify the technique by resecting the ureteral orifice and pulling on the ureter from a single loin incision has been associated with a significant rate of recurrences at the site of the resected orifice.31 A bigger dilemma was faced when dealing with patients with solitary kidneys—congenital or by a previous nephrectomy—with compromised renal function, or with bilateral urothelial tumors.10 Nephroureterectomy in these patients would result in an anatomic or functional anephric state, leading to chronic hemodialysis.80 Long-term hemodialysis is associated with significant morbidity and mortality, with a 5-year survival rate of only 19% in patients 65 to 74 years old.27 Although the incidence of bilateral TCC is generally low, Balkan nephropathy and occupational exposures are associated more commonly with multiple and bilateral upper urinary tract TCC than are tumors with other causes.50, 89 Balkan nephropathy also is accompanied by a certain degree of renal impairment, and urothelial tumors associated with it are generally of low grade and exhibit an indolent behavior.65 The previously mentioned circumstances and the possible need for nephrotoxic chemotherapy to control advanced disease raised a big question about how necessary and vital it is to treat every filling defect of the upper urinary system with nephroureterectomy, especially because 50% to 82% of upper tract tumors treated with nephroureterectomy in the different series were low-stage and low-grade (GI-II, Ta-T1).12, 14, 15, 48, 57, 69 The behavior of such tumors is usually indolent, and the risk for invasiveness and metastasis is low.35, 37, 56, 57

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Address reprint requests to Michel E. Jabbour, MD, Urology Department, Hotel Dieu Hospital, Beirut, Lenanon, e-mail: michelj@cyberia.net.lb


© 2000  W. B. Saunders Company. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 27 - N° 4

P. 739-750 - novembre 2000 Ritorno al numero
Articolo precedente Articolo precedente
  • LAPAROSCOPIC PARTIAL NEPHRECTOMY : The European Experience
  • Jens J. Rassweiler, Claude Abbou, Günter Janetschek, Klaus Jeschke
| Articolo seguente Articolo seguente
  • URETEROSCOPIC MANAGEMENT OF PATIENTS WITH UPPER TRACT TRANSITIONAL CELL CARCINOMA
  • Dean G. Assimos, M. Craig Hall, Jeffrey H. Martin

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.